Crewe Advisors’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-438
Closed -$7.13K – 966
2024
Q1
$7.13K Buy
438
+223
+104% +$3.49K ﹤0.01% 671
2023
Q4
$3.2K Buy
+215
New +$2.44K ﹤0.01% 276
2023
Q2
– Sell
-238
Closed -$2.24K – 915
2023
Q1
$2.24K Hold
238
– – ﹤0.01% 715
2022
Q4
$2.91K Sell
238
-129
-35% -$1.61K ﹤0.01% 774
2022
Q3
$5K Hold
367
– – ﹤0.01% 840
2022
Q2
$7K Buy
+367
New +$8.69K ﹤0.01% 682

Other funds holding ELAN

Crewe Advisors's ELAN Position: Q2 2024 in Review

Crewe Advisors sold out of Elanco Animal Health (ELAN) in Q2 2024, closing a stake of 438 shares — an estimated $7.13K sold.

Crewe Advisors first reported a position in ELAN in Q2 2022 and held it in 6 quarters. The position peaked at $7.13K in Q1 2024. 402 funds tracked by Wall St. Rank hold ELAN as of Q2 2024.

  • Crewe Advisors reported no remaining Elanco Animal Health position as of Q2 2024 after selling out during the quarter.
  • Crewe Advisors sold 438 Elanco Animal Health shares in Q2 2024, an estimated $7.13K.
  • Crewe Advisors first reported a position in Elanco Animal Health in Q2 2022 and held it in 6 quarters.
  • Crewe Advisors's Elanco Animal Health position peaked at $7.13K in Q1 2024.
  • 402 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2024.

Based on Crewe Advisors's 13F filing for Q2 2024, filed 29 Jul 2024.